Insecticides (India) Limited (532851) Earnings Call Transcripts
Insecticides (India) Limited's Latest Earnings Call - Q4 FY2026
Insecticides (India) Limited reported a steady performance for Q4 FY '26, with revenue increasing 19% year-over-year, driven by both B2C and B2B segments. For the full fiscal year, revenue rose to INR 2,140 crores, a 7% increase, while net profit slightly declined to INR 139 crores due to higher tax provisions. Management remains cautiously optimistic about FY '27, indicating potential for continued growth despite challenges in raw material pricing and geopolitical tensions.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | INR 2,140 crores (beat) |
| Net Profit | INR 139 crores (miss) |
| Gross Profit Margin | 31.5% (beat) |
| EBITDA | INR 227 crores (beat) |
| ROCE | 16.1% (beat) |
| Volume Growth (Q4) | 5% (inline) |
Guidance from management
Management remains cautiously optimistic about FY '27, expecting decent growth supported by pricing actions and improved demand visibility as the season progresses. They indicated that the CapEx requirement will remain nominal at INR 25-30 crores.
What management said
Yes, that's correct actually provided we are able to encash that. So there is every effort that we should take the advantage of the current situation because we generally start our planning from Diwali and this Diwali to Holi exercise whatever we buy and whatever we [indiscernible] et cetera. So yes, this year, since the prices have gone up, so this will be particularly helpful. So we are keeping the finger crossed f...
Yes, that's very, very important actually, and we are trying to build up the brand in that fashion so that we are able to attract the CDMO relationships. So already there are certain things which are in the initial stages and there will be some small supplies which will be going to trial purposes. So when I say trials, trials that we won contingent trials also. So we have to build that relationship stronger and we ha...
What analysts pressed on
Analysts expressed concerns regarding the impact of rising raw material costs on margins and the company's ability to maintain profitability amidst geopolitical tensions. There were also questions about the effectiveness of inventory management strategies and the potential for unsold inventory.
Main topics on the call
- Strong Revenue Growth — In Q4 FY '26, Insecticides India achieved a revenue growth of approximately 19%, with premium products leading the charge at a 24% increase. Management noted, "The overall momentum in the business continues to strengthen...
- Challenges from Raw Material Costs — Management highlighted ongoing supply-side constraints and rising raw material prices, stating that prices have increased sharply by nearly 10% for certain products. This has created a more supplier-driven market environ...
- Product Premiumization Strategy — The company continues to focus on premiumization, having launched over 25 new products in the last three years. Management emphasized that "this growing farmer confidence gives us strong visibility and confidence for the...
- Operational Readiness and Inventory Management — In preparation for the upcoming season, Insecticides India has maintained comfortable inventory levels, which management believes will allow them to capitalize on market demand as the monsoon season approaches.
Read the full Insecticides (India) Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Insecticides (India) Limited
Insecticides (India) Limited (532851) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 23 calls on record spanning February 10, 2020 to May 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 23 Insecticides (India) Limited earnings call transcripts on record, spanning February 10, 2020 to May 28, 2026. Based on this history, Insecticides (India) Limited reports quarterly. The most recent call on file is dated May 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.
| Quarter | Date | |
|---|---|---|
| Q4 FY2026 | May 28, 2026 | Read transcript → |
| Q4 FY2025 | May 28, 2025 | Read transcript → |
| Q3 FY2025 | Feb 10, 2025 | Read transcript → |
| Q2 FY2025 | Nov 12, 2024 | Read transcript → |
| Q1 FY2025 | Aug 9, 2024 | Read transcript → |
| Q4 FY2024 | May 29, 2024 | Read transcript → |
| Q3 FY2024 | Feb 6, 2024 | Read transcript → |
| Q2 FY2024 | Nov 3, 2023 | Read transcript → |
| Q1 FY2024 | Aug 11, 2023 | Read transcript → |
| Q4 FY2023 | May 31, 2023 | Read transcript → |
| Q3 FY2023 | Feb 14, 2023 | Read transcript → |
| Q2 FY2023 | Nov 8, 2022 | Read transcript → |
| Q1 FY2023 | Aug 17, 2022 | Read transcript → |
| Q4 FY2022 | May 27, 2022 | Read transcript → |
| Q3 FY2022 | Feb 11, 2022 | Read transcript → |
| Q2 FY2022 | Nov 16, 2021 | Read transcript → |
| Q1 FY2022 | Aug 11, 2021 | Read transcript → |
| Q4 FY2021 | Jun 21, 2021 | Read transcript → |
| Q3 FY2021 | Feb 8, 2021 | Read transcript → |
| Q2 FY2021 | Nov 10, 2020 | Read transcript → |
| Q1 FY2021 | Aug 17, 2020 | Read transcript → |
| Q4 FY2020 | Jun 26, 2020 | Read transcript → |
| Q3 FY2020 | Feb 10, 2020 | Read transcript → |